Molecular Matrix Snags FDA Clearance for Bone Graft Technology

Molecular Matric received FDA 510(k) clearance for its musculoskeletal technology for bone regeneration – Osteo-P.

The bone graft substitute is made with a hyper-crosslinked carbohydrate polymer.

The musculoskeletal solution is intended for filling bone defects caused by surgical procedures or traumatic injuries.